Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk
Stacey M. Frumm(Dana-Farber Cancer Institute), Maximilian Stahl(Harvard University), Eric S. Winer(Providence College), Roman M. Shapiro(Boston University), Marlise R. Luskin(Dana-Farber Cancer Institute), Corey Cutler(Harvard University), John Koreth(Otsuka (Japan)), Coleman Lindsley, Vincent T. Ho(Dana-Farber Cancer Institute), Tariq Kewan(Yale University), Mahasweta Gooptu(Harvard University), Haesook T. Kim(Dana-Farber Cancer Institute), Martha Wadleigh(Dana-Farber Cancer Institute), Shai Shimony(Twitter (United States)), Evan C. Chen(Dana-Farber Cancer Institute), Christopher J. Gibson(Otsuka (Japan)), Abdulrahman Alhajahjeh(University of Jordan), Joseph H. Antin(Dana-Farber Cancer Institute), Benjamin Rolles(Brigham and Women's Hospital), Rizwan Romee(Washington University in St. Louis), Amar H. Kelkar(Harvard University), Amer M. Zeidan(Yale Cancer Center), Robert J. Soiffer(Dana-Farber Cancer Institute), Andrew A. Lane(Dana-Farber Cancer Institute), Richard M. Stone(Dana-Farber Cancer Institute), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Sarah Nikiforow(Otsuka (Japan))
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k